Ken Coleman

530 total citations
12 papers, 456 citations indexed

About

Ken Coleman is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, Ken Coleman has authored 12 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 5 papers in Pharmacology and 3 papers in Infectious Diseases. Recurrent topics in Ken Coleman's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). Ken Coleman is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). Ken Coleman collaborates with scholars based in United States, United Kingdom and Canada. Ken Coleman's co-authors include Christine Miossec, Anne-Marie Girard, Premavathy Levasseur, John Pace, Monica Borgonovi, Henri Merdjan, David M. Shlaes, George L. Drusano, Wright W. Nichols and Ian Chopra and has published in prestigious journals such as Nature Biotechnology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Ken Coleman

12 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Coleman United States 9 331 245 151 91 79 12 456
Tiffany Palmer United States 4 406 1.2× 266 1.1× 139 0.9× 78 0.9× 100 1.3× 8 459
Premavathy Levasseur Belgium 7 401 1.2× 323 1.3× 169 1.1× 97 1.1× 45 0.6× 7 436
Kai‐Tai Chang United States 15 402 1.2× 320 1.3× 155 1.0× 147 1.6× 116 1.5× 20 560
Mototsugu Yamada Japan 7 223 0.7× 165 0.7× 108 0.7× 33 0.4× 101 1.3× 8 362
Denia Frank Germany 9 260 0.8× 128 0.5× 90 0.6× 41 0.5× 130 1.6× 12 355
Anima Poudyal Australia 7 530 1.6× 329 1.3× 173 1.1× 76 0.8× 131 1.7× 10 634
Eliana S. Armstrong United States 12 509 1.5× 292 1.2× 160 1.1× 85 0.9× 238 3.0× 17 722
Elizabeth Gradelski United States 13 260 0.8× 261 1.1× 129 0.9× 57 0.6× 114 1.4× 19 513
B Kolek United States 13 294 0.9× 307 1.3× 206 1.4× 45 0.5× 151 1.9× 16 637

Countries citing papers authored by Ken Coleman

Since Specialization
Citations

This map shows the geographic impact of Ken Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Coleman more than expected).

Fields of papers citing papers by Ken Coleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Coleman. The network helps show where Ken Coleman may publish in the future.

Co-authorship network of co-authors of Ken Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Coleman. A scholar is included among the top collaborators of Ken Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Coleman. Ken Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Levasseur, Premavathy, Anne-Marie Girard, Christine Miossec, John Pace, & Ken Coleman. (2015). In Vitro Antibacterial Activity of the Ceftazidime-Avibactam Combination against Enterobacteriaceae, Including Strains with Well-Characterized β-Lactamases. Antimicrobial Agents and Chemotherapy. 59(4). 1931–1934. 50 indexed citations
2.
Coleman, Ken, Premavathy Levasseur, Anne-Marie Girard, et al.. (2014). Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 58(6). 3366–3372. 79 indexed citations
3.
Gavrish, Ekaterina, Chao Chen, E. Jeffrey North, et al.. (2014). In Vitro and In Vivo Activities of HPi1, a Selective Antimicrobial against Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 58(6). 3255–3260. 8 indexed citations
4.
LaFleur, Michael D., Lingmei Sun, John H. Keating, et al.. (2013). Potentiation of Azole Antifungals by 2-Adamantanamine. Antimicrobial Agents and Chemotherapy. 57(8). 3585–3592. 30 indexed citations
5.
Coleman, Ken. (2011). Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Current Opinion in Microbiology. 14(5). 550–555. 197 indexed citations
6.
Bai, Yongsheng, et al.. (2007). Effect of Cetylpyridinium Chloride (Cecure® CPC Antimicrobial) on the Refrigerated Shelf Life of Fresh Boneless, Skinless Broiler Thigh Meat. International Journal of Poultry Science. 6(2). 91–94. 8 indexed citations
7.
Coleman, Ken. (2006). Extending the life of β-lactam antibiotics: New β-lactamase inhibitors. Drug Discovery Today Therapeutic Strategies. 3(2). 183–188. 6 indexed citations
8.
Coleman, Ken. (2004). Recent advances in the treatment of Gram-positive infections. Drug Discovery Today Therapeutic Strategies. 1(4). 455–460. 26 indexed citations
9.
Coleman, Ken. (1995). Section Review: Anti-infectives: An update on β-lactamases and β-lactamase inhibitors. Expert Opinion on Investigational Drugs. 4(8). 693–704. 13 indexed citations
10.
Coleman, Ken, et al.. (1994). Bacterial resistance mechanisms as therapeutic targets. Journal of Antimicrobial Chemotherapy. 33(6). 1091–1116. 36 indexed citations
11.
Coleman, Ken, et al.. (1989). Japan Roundup. Nature Biotechnology. 7(1). 30–30. 1 indexed citations
12.
Coleman, Ken, et al.. (1989). Japan Roundup. Nature Biotechnology. 7(4). 332–332. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026